About SYNTHIA™
SYNTHIA™ Retrosynthesis Software is a product of the Life Science business of Merck KGaA, Darmstadt, Germany.
Retrosynthesis is a widely used problem-solving technique in organic chemistry that begins with a target molecule and works iteratively backward to identify simpler starting compounds. SYNTHIA™ Retrosynthesis Software empowers organic chemists by expanding their expertise and liberating them from the time-consuming manual processes involved in synthetic route planning.
Engineered by organic chemists and computer scientists over the course of 21 years, SYNTHIA™ Retrosynthesis Software harnesses also the power of artificial intelligence (AI) in chemistry to curate information and predict reactions for computer-aided synthetic design of optimal synthetic routes.
Based on years of development as Chematica, published in August 2012, then further enhancement as SYNTHIA™ Retrosynthesis Software, this unique tool enables chemists to easily navigate through viable pathways that can be executed at the bench.
SYNTHIA™ Retrosynthesis Software is consistently enhanced by incorporating user feedback to refine every facet, including usability, security, scalability, and chemistry knowledge, thereby offering a more intuitive and functional experience.
With a catalog of over 12 million commercially available starting materials and building blocks, SYNTHIA™ provides access to a broad portfolio of available chemistry through the Sigma-Aldrich® web shop.
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.
The life science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the US and Canada. Merck KGaA, Darmstadt, Germany is a global science and technology company with more than 64,000 employees in 66 countries.
SYNTHIA™ Retrosynthesis Software is a trademark of Merck KGaA, Darmstadt, Germany.